State of the Art Symposium 5

Sponsored by Astellas Pharma

Title Immunosuppression tailored for beta cell replacement
Creators Diego Cantarovich
Raja Kandaswamy
Olivier Thaunat
Lectures Metabolic Instruction of Immunity: immunometabolism and beta cell replacement
Targeting CTLA4 to minimize CNI in pancreas or islet transplantation
New immunosuppressive drugs : what’s in the pipeline ?
Tolerance induction in beta cell replacement
Why you should attend Most (if not all) immunosuppressive drugs currently used in solid organ transplantation are ill-adapted to recipients of beta cell transplants because they are either directly toxic to the graft and/or have major interferences with glycemic control.
What you will learn How drugs impacting glucose metabolism impact the immune response
What is the potential of new immunosuppressive drugs for beta-cell replacement
How long will it take to induce tolerance to allogenic beta cells?
plateforme dédiée aux manifestations
Tel. : 01 84 17 20 55 / 06 89 19 34 06
E-mail :
La première plateforme Française de gestion de manifestations regroupant la billeterie, la gestion des hébergements, une boutique en ligne, la gestion des surfaces d'exposition et la gestion complète du programme scientifique.
Organisation de Congrès, manifestations, Séminiaires, Colloques